Showing results (681-690 of 795) with videos related to
Sort By:
Pageof 80
The Journal of Clinical Psychiatry|January 5, 2023
Risk of Poor Neonatal Adaptation Syndrome Among Infants Exposed to Second-Generation Atypical Antipsychotics Compared to Antidepressants: Results From the National Pregnancy Registry for Psychiatric MedicationsAdele C Viguera, Sara A McElheny, Phoebe S Caplin, et al.Menopause (New York, N.Y.)|July 16, 2020
The association between weight-promoting medication use and weight gain in postmenopausal women: findings from the Women's Health InitiativeFatima Cody Stanford, Hellas Cena, Ginevra Biino, et al.The Lancet. Psychiatry|March 19, 2026
The efficacy and safety of cannabinoids for the treatment of mental disorders and substance use disorders: a systematic review and meta-analysisJack Wilson, Olivia Dobson, Andrew Langcake, et al.Biological Psychiatry|April 1, 1989
Specificity of the salivary cortisol dexamethasone suppression test across psychiatric diagnosesD L Copolov, R T Rubin, G W Stuart, et al.Journal of Medicinal Chemistry|June 1, 1991
Naphtho and benzo analogues of the kappa opioid agonist trans-(+/-)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl] benzeneacetamideJ P Freeman, E T Michalson, S V D'Andrea, et al.The Journal of Clinical Psychiatry|December 30, 2006
Omega-3 fatty acids: evidence basis for treatment and future research in psychiatryMarlene P Freeman, Joseph R Hibbeln, Katherine L Wisner, et al.Psychoneuroendocrinology|January 1, 1985
Pre- and post-dexamethasone salivary cortisol concentrations in major depressionD L Copolov, R T Rubin, A J Mander, et al.Bioorganic & Medicinal Chemistry|September 11, 1999
Syntheses of benzoquinolizidine and benzoindolizidine derivatives as anti-amnesic agentsS Zhao, M J Totleben, J P Freeman, et al.Addiction (Abingdon, England)|May 3, 2025
Effectiveness and safety of psychosocial interventions for the treatment of cannabis use disorder: A systematic review and meta-analysisMonika Halicka, Thomas L Parkhouse, Katie Webster, et al.Psychological Medicine|July 30, 2011
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-beingC J A Morgan, C Gardener, G Schafer, et al.Pageof 80